Brazil In-Vitro Diagnostics Market is predicted to reach USD 1.8 Billion by 2030

According to the study by Next Move Strategy Consulting, the Brazil In-Vitro Diagnostics Market size is predicted to reach USD 1.8 billion, at a CAGR of 3.1% by 2030.

Request a FREE Sample: https://www.nextmsc.com/brazil-in-vitro-diagnostics-market/request-sample

The rising incidence of chronic diseases such as diabetes, cardiovascular diseases, and cancer is a major driver for the increased demand for diagnostic tests in Brazil.

Brazil's growing elderly population is significantly impacting the demand for IVD products and services. As people age, they become more susceptible to a range of health conditions such as hypertension, diabetes, arthritis, and various types of cancers, all of which require regular monitoring and diagnostic testing.

The promising players operating in the Brazil in-vitro diagnostics industry include Roche Holding AG, Abbott Laboratories, Thermo Fisher Scientific Inc, Danaher Corporation, Becton, Dickinson and Company, Siemens Healthineers AG, bioMérieux SA, Sysmex Corporation, QIAGEN N.V., and Bio-Rad Laboratories, Inc., and others.